---
title: The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients
  receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma
date: '2023-07-31'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37525244/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230801180916&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: These data highlight the prognostic utility of the CAR-HEMATOTOX
  score for both toxicity and treatment response in multiple myeloma patients receiving
  BCMA-directed CAR-T. The score may guide toxicity management (e.g. anti-infective
  prophylaxis, early G-CSF, stem cell boost) and help to identify suitable CAR-T ...'
disable_comments: true
---
CONCLUSIONS: These data highlight the prognostic utility of the CAR-HEMATOTOX score for both toxicity and treatment response in multiple myeloma patients receiving BCMA-directed CAR-T. The score may guide toxicity management (e.g. anti-infective prophylaxis, early G-CSF, stem cell boost) and help to identify suitable CAR-T ...